Related Experiment Video
Updated: Feb 12, 2026

Accurate and Phenol Free DNA Sexing of Day 30 Porcine Embryos by PCR
Published on: February 14, 2016
Readmission and complications within 30 days after intrathecal baclofen pump placement
Sandi K Lam1, Rory R Mayer1, Aditya Vedantam1
1Division of Pediatric Neurosurgery, Department of Neurosurgery, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Insights
Seven percent of pediatric patients require readmission within 30 days of intrathecal baclofen (ITB) pump placement, with surgical site infection being the most common reason for reoperation.
Area of Science:
- Pediatric Surgery
- Neurosurgery
- Medical Device Outcomes
Background:
- Intrathecal baclofen (ITB) pump placement is a common procedure for managing spasticity in children.
- Understanding short-term outcomes and risk factors is crucial for optimizing patient care and surgical quality.
Purpose of the Study:
- To analyze 30-day outcomes following ITB pump placement in pediatric patients.
- To identify risk factors associated with readmission, reoperation, and perioperative complications.
Main Methods:
- Utilized the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database (2012-2014).
- Included patients aged 0-18 years undergoing ITB pump placement.
- Performed multivariate regression analysis on preoperative and perioperative data to assess outcomes within 30 days.
Main Results:
- A total of 423 pediatric surgeries were analyzed.
- The 30-day readmission rate was 7.3%, with surgical site infection being the primary indication for reoperation in 64.5% of readmitted patients.
- Female sex was linked to lower readmission risk, while longer initial hospital stays (≥3 days) increased the risk of adverse perioperative events.
Conclusions:
- This study provides national insights into 30-day perioperative outcomes for pediatric ITB pump placement.
- Findings highlight areas for quality improvement in clinical practice regarding ITB pump procedures.
Aim:
To describe 30-day outcomes after intrathecal baclofen (ITB) pump placement in children and identify risk factors for readmission, reoperation, and perioperative complication using the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database.
Method:
Patients aged 0 to 18 years who underwent ITB pump placement (2012-2014) comprised the study cohort defined in the database. Multivariate regression analysis was performed using preoperative and perioperative data from the American College of Surgeons' NSQIP-P database. Outcomes of interest within 30 days of surgery were (1) unplanned reoperation; (2) unplanned readmission; and (3) composite postoperative event, including complication, reoperation, and/or readmission.
Results:
We identified 423 surgeries; 246 (58.2%) patients were male, 177 (41.8%) patients were female. Median age was 12 years and 11 months. Median operative time was 70 minutes (interquartile range 56-97min). Mean length of stay was 3.8 days. The patient population had a high number of medical comorbidities. The overall readmission rate was 7.3%; mean postoperative admission date was 14.1 days after surgery. Of readmitted patients, 64.5% underwent reoperation. The most common indication for reoperation was surgical site infection. Female sex was associated with decreased risk of readmission (odds ratio [OR] 0.25, 95% confidence interval [CI] 0.09-0.65; p=0.01); American Society of Anesthesiologists Classification of greater than or equal to 3 was associated with decreased risk of unplanned return to surgery (OR 0.26, 95% CI 0.11-0.66; p=0.04); length of stay greater than or equal to 3 days at index surgery was associated with increased risk of composite 30-day perioperative event (OR 2.33, 95% CI 1.29-4.20; p=0.01).
Interpretation:
Our data provide national perspectives on 30-day perioperative outcomes for ITB pump placement in children. Results illustrate NSQIP-P database collection methodology and highlight opportunities for quality improvement in clinical practice.
What This Paper Adds:
Seven percent of patients who underwent intrathecal baclofen pump placement required readmission within 30 days. The most common indication for reoperation was surgical site infection.
Related Concept Videos
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Hemodialysis II: Procedure and Complications
Pumped Concrete
For direct-acting pumps, the concrete enters the pump via the inlet valve under the action of gravity and suction created by the movement of the piston. This concrete is then forced into the pipeline and out through the outlet valve by the forward movement...
Refrigerators and Heat Pumps
A household refrigerator removes heat from...
Pneumonia III: Complications and Assessment

